This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jan 10;26(2):335-6; author reply 336-8.

doi: 10.1200/JCO.2007.14.8411.

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, Philippe Moerman, Nathalie Pochet, Wouter Hendrickx, Hans Wildiers, Robert Paridaens, Ann Smeets, Marie-Rose Christiaens, Ignace Vergote, Karin Leunen, Frederic Amant, Patrick Neven

PMID: 18182677
DOI: 10.1200/JCO.2007.14.8411

Comment

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

Leen De Maeyer et al. J Clin Oncol. 2008.

. 2008 Jan 10;26(2):335-6; author reply 336-8.

doi: 10.1200/JCO.2007.14.8411.

Authors

Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, Philippe Moerman, Nathalie Pochet, Wouter Hendrickx, Hans Wildiers, Robert Paridaens, Ann Smeets, Marie-Rose Christiaens, Ignace Vergote, Karin Leunen, Frederic Amant, Patrick Neven

PMID: 18182677
DOI: 10.1200/JCO.2007.14.8411

No abstract available

PubMed Disclaimer

Comment on

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17. J Clin Oncol. 2007. PMID: 17876012

Similar articles

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17. J Clin Oncol. 2007. PMID: 17876012
Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
Mehta RS. Mehta RS. J Clin Oncol. 2008 Jul 1;26(19):3286-8; author reply 3288. doi: 10.1200/JCO.2008.17.1116. J Clin Oncol. 2008. PMID: 18591566 No abstract available.
Triple-negative breast cancer: a short review.
Elias AD. Elias AD. Am J Clin Oncol. 2010 Dec;33(6):637-45. doi: 10.1097/COC.0b013e3181b8afcf. Am J Clin Oncol. 2010. PMID: 20023571 Review.
E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma.
Kwon MJ, Nam ES, Cho SJ, Park HR, Shin HS, Park JH, Park CH, Lee WJ. Kwon MJ, et al. Ann Surg Oncol. 2010 Feb;17(2):564-71. doi: 10.1245/s10434-009-0767-z. Epub 2009 Oct 20. Ann Surg Oncol. 2010. PMID: 19841979
Disease related indicators for a proper choice of adjuvant treatments.
Hayes DF. Hayes DF. Breast. 2011 Oct;20 Suppl 3:S162-4. doi: 10.1016/S0960-9776(11)70317-4. Breast. 2011. PMID: 22015287 Review.

See all similar articles

Cited by

Single progesterone receptor-positive phenotype has the similar clinicopathological features and outcome as triple-negative subtype in metastatic breast cancer.
Luo Y, Pu H, Li F, Qian S, Chen J, Zhao X, Hou L. Luo Y, et al. Front Oncol. 2023 Feb 24;13:1029648. doi: 10.3389/fonc.2023.1029648. eCollection 2023. Front Oncol. 2023. PMID: 36910652 Free PMC article.
Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ER^-PR⁺HER2^-) breast cancer.
Rala de Paula BH, Crocamo S, Bines J. Rala de Paula BH, et al. Transl Breast Cancer Res. 2022 Oct 28;4:8. doi: 10.21037/tbcr-22-41. eCollection 2023. Transl Breast Cancer Res. 2022. PMID: 38751458 Free PMC article. No abstract available.
Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study.
Park HL, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS, Ma H, Clague J, Reynolds P, Lacey JV Jr, Bernstein L, Anton-Culver H. Park HL, et al. BMC Cancer. 2016 Jan 12;16:14. doi: 10.1186/s12885-015-2036-9. BMC Cancer. 2016. PMID: 26758508 Free PMC article.
The Role of Progesterone Receptors in Breast Cancer.
Li Z, Wei H, Li S, Wu P, Mao X. Li Z, et al. Drug Des Devel Ther. 2022 Jan 26;16:305-314. doi: 10.2147/DDDT.S336643. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35115765 Free PMC article. Review.
Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients.
Ahn JH, Choi SB, Park JM, Kim JY, Park HS, Kim SI, Park BW, Park S. Ahn JH, et al. Cancers (Basel). 2021 Oct 6;13(19):5007. doi: 10.3390/cancers13195007. Cancers (Basel). 2021. PMID: 34638491 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program